Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Toshiba deploys portable ultrasound at Fla. facility

Florida Hospital Fish Memorial, based in Orange City, Fla., has selected Toshiba America Medical Systems portable ultrasound technology, the Xario XG ultrasound system.

Four states net CMS EHR incentive funds

The Centers for Medicare & Medicaid Services (CMS) has granted Medicaid programs in Hawaii, Massachusetts, North Dakota and Ohio federal matching funds for state planning activities necessary to implement the EHR incentive program established by the American Recovery and Reinvestment Act (ARRA).

Institute awarded $3.3M for prostate imaging study

Riverside Research Institute has been awarded a $3.3 million grant by the National Institutes of Health (NIH) for a research project combining ultrasound and MR methods for prostate cancer imaging.

EU clears U-Systems breast ultrasound as mammo adjunct

U-Systems has received approval to market its somo.v Automated Breast Ultrasound system as an adjunct to mammography for screening asymptomatic women for breast cancer in the European Union.

Imaging Biometrics, UPenn team for tumor monitoring technology

Advanced visualization company Imaging Biometrics has signed a global license agreement with the University of Pennsylvania (UPenn) for the development and commercialization of technology that may lead to an automated way to evaluate a tumors response to various treatment therapies.

Georgia technologist indicted for false mammo reporting

A Georgia grand jury indicted former Perry Hospital employee Rachael Michelle Rapraeger Sept. 7 for entering negative mammography results without a physician's review.

Study: Simplified Framingham risk score could misclassify millions

Use of the conventional simplified version of the Framingham risk score model may underestimate the risk of cardiovascular (CV) events in millions of Americans, according to a study published online Sept. 8 in the Journal of General Internal Medicine.

Nucletron names new executive VP of sales

Radiotherapy systems developer Nucletron has appointed Peter Kingma as executive vice president of global sales and service.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.